1887

Journal of Medical Microbiology logo

Volume 70, Issue 4

Whole genome sequencing of a clinical drug resistant isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms Open Access

Abstract

is an opportunistic pathogen accounting for the majority of cases of infections. Currently, are developing resistance towards different classes of antifungal drugs and this has become a global health burden that does not spare Lebanon. This study aims at determining point mutations in genes known to be involved in resistance acquisition and correlating resistance to virulence and ergosterol content in the azole resistant isolate CA77 from Lebanon. This pilot study is the first of its kind to be implemented in Lebanon. We carried out whole genome sequencing of the azole resistant isolate CA77 and examined 18 genes involved in antifungal resistance. To correlate genotype to phenotype, we evaluated the virulence potential of this isolate by injecting it into BALB/c mice and we quantified membrane ergosterol. Whole genome sequencing revealed that eight out of 18 genes involved in antifungal resistance were mutated in previously reported and novel residues. These genotypic changes were associated with an increase in ergosterol content but no discrepancy in virulence potential was observed between our isolate and the susceptible control strain SC5314. This suggests that antifungal resistance and virulence potential in this antifungal resistant isolate are not correlated and that resistance is a result of an increase in membrane ergosterol content and the occurrence of point mutations in genes involved in the ergosterol biosynthesis pathway.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antifungal resistance , azoles , Candida albicans , ergosterol , virulence and whole genome sequencing
© 2021 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001351
2021-04-28
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/70/4/jmm001351.html?itemId=/content/journal/jmm/10.1099/jmm.0.001351&mimeType=html&fmt=ahah

References

  1. Vazquez JA, Sobel JD. Candidiasis. In Kauffman CA, Pappas PG, Sobel JD, Dismukes WE. (editors) Essentials of Clinical Mycology, 2nd ed. New York: Springer; 2011 pp 167–206
     [Google Scholar]
  2. Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008; 12:204 [View Article]
     [Google Scholar]
  3. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4:119–128 [View Article]
     [Google Scholar]
  4. Campoy S, Adrio JL. Antifungals. Biochem Pharmacol 2017; 133:86–96 [View Article]
     [Google Scholar]
  5. Onyewu C, Blankenship JR, Del Poeta M, Heitman J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei . Antimicrob Agents Chemother 2003; 47:956–964 [View Article]
     [Google Scholar]
  6. Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 2000; 44:2693–2700 [View Article]
     [Google Scholar]
  7. Perlin DS. Mechanisms of echinocandin antifungal drug resistance. Ann N Y Acad Sci 2015; 1354:1–11 [View Article]
     [Google Scholar]
  8. Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 2015; 5:a019752 [View Article]
     [Google Scholar]
  9. Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med 2014; 4:a019703 [View Article]
     [Google Scholar]
  10. Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 2017; 17:e383–e392 [View Article]
     [Google Scholar]
  11. Barada G, Basma R, Khalaf RA. Microsatellite DNA identification and genotyping of Candida albicans from Lebanese clinical isolates. Mycopathologia 2008; 165:115–125 [View Article]
     [Google Scholar]
  12. Basma R, Barada G, Ojaimi N, Khalaf RA. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates. Mycoses 2009; 52:141–148 [View Article]
     [Google Scholar]
  13. Bitar I, Khalaf RA, Harastani H, Tokajian S. Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients. Biomed Res Int 2014; 2014:1–10 [View Article][PubMed]
     [Google Scholar]
  14. Araj GF, Asmar RG, Avedissian AZ. Candida profiles and antifungal resistance evolution over a decade in Lebanon. J Infect Dev Ctries 2015; 9:997–1003 [View Article]
     [Google Scholar]
  15. Toutounji M, Tokajian S, Khalaf RA. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin. Fungal Genetics and Biology 2019; 127:12–22 [View Article]
     [Google Scholar]
  16. Ghaddar N, Anastasiadis E, Halimeh R, Ghaddar A, Dhar R et al. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. BMC Infect Dis 2020; 20:1–9 [View Article]
     [Google Scholar]
  17. Yazbek S, Barada G, Basma R, Mahfouz J, Khalaf RA. Significant discrepancy between real-time PCR identification and hospital identification of C. albicans from Lebanese patients. Med Sci Monit 2007; 13:MT7–12
     [Google Scholar]
  18. Liu TT, Lee REB, Barker KS, Lee RE, Wei L, REB L, Rogers PD et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans . Antimicrob Agents Chemother 2005; 49:2226–2236 [View Article]
     [Google Scholar]
  19. Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS et al. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 2017; 7:2173 [View Article]
     [Google Scholar]
  20. Ruiz-Herrera J, Elorza MV, Valentín E, Sentandreu R. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res 2006; 6:14–29 [View Article][PubMed]
     [Google Scholar]
  21. Awad A, El Khoury P, Wex B, Khalaf RA. Proteomic analysis of a Candida albicans PGA1 null strain. EuPA Open Proteom 2018; 18:1–6 [View Article]
     [Google Scholar]
  22. CLSI Performance standard for antifungal susceptibility testing of filamentous fungi. Available from. https://clsi.org/media/3682/m61ed2_sample.pdf
  23. Daher JY, Koussa J, Younes S, Khalaf RA. The Candida albicans Dse1 protein is essential and plays a role in cell wall rigidity, biofilm formation, and virulence. Interdiscip Perspect Infect Dis 2011; 2011:1–9 [View Article]
     [Google Scholar]
  24. Hashash R, Younes S, Bahnan W, El Koussa J, Maalouf K et al. Characterisation of PGA1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation. Mycoses 2011; 54:491–500 [View Article]
     [Google Scholar]
  25. Bahnan W, Koussa J, Younes S, Rizk MA, Khalil B et al. Deletion of the Candida albicans PIR32 results in increased virulence, stress response, and upregulation of cell wall chitin deposition. Mycopathologia 2012; 174:107–119 [View Article]
     [Google Scholar]
  26. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans . J Clin Microbiol 1999; 37:3332–3337 [View Article]
     [Google Scholar]
  27. Chin C-S, Alexander DH, Marks P, Klammer AA, Drake J et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 2013; 10:563–569 [View Article]
     [Google Scholar]
  28. Chin C-S, Peluso P, Sedlazeck FJ, Nattestad M, Concepcion GT et al. Phased diploid genome assembly with single-molecule real-time sequencing. Nat Methods 2016; 13:1050–1054 [View Article]
     [Google Scholar]
  29. Bitar I, Medvecky M, Amlerova J, Papagiannitsis CC, Hrabak J. Frequency of mutations associated with resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis isolates. J Glob Antimicrob Resist 2020; 22:275–282 [View Article]
     [Google Scholar]
  30. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article]
     [Google Scholar]
  31. Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 2004; 14:1394–1403 [View Article]
     [Google Scholar]
  32. Wang JM, Bennett RJ, Anderson MZ. The genome of the human pathogen Candida albicans is shaped by mutation and cryptic sexual recombination. mBio 2018; 9:e01205–01218 [View Article]
     [Google Scholar]
  33. Hrabak J, Bitar I, Papagiannitsis CC. Combination of mass spectrometry and DNA sequencing for detection of antibiotic resistance in diagnostic laboratories. Folia Microbiol 2020; 65:233–243 [View Article]
     [Google Scholar]
  34. Löffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett 2000; 185:59–63 [View Article]
     [Google Scholar]
  35. Rocha MFG, Bandeira SP, de Alencar LP, Melo LM, Sales JA et al. Azole resistance in Candida albicans from animals: highlights on efflux pump activity and gene overexpression. Mycoses 2017; 60:462–468 [View Article]
     [Google Scholar]
  36. Sitterlé E, Coste AT, Obadia T, Maufrais C, Chauvel M et al. Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins. J Antimicrob Chemother 2020; 75:835–848 [View Article]
     [Google Scholar]
  37. Haque A, Rai V, Bahal BS, Shukla S, Lattif AA et al. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans. Biochem Biophys Res Commun 2007; 352:491–497 [View Article][PubMed]
     [Google Scholar]
  38. Feng W, Yang J, Ji Y, Xi Z, Yang L et al. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis. Lett Appl Microbiol 2020; 70:95–101 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001351
Loading
Whole genome sequencing of a clinical drug resistant Candida albicans isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms
J. Med. Microbiol. 70, 001351 (2021); https://doi.org/10.1099/jmm.0.001351
/content/journal/jmm/10.1099/jmm.0.001351
/content/journal/jmm/10.1099/jmm.0.001351
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error